These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7148647)

  • 1. Hemodynamic and myocardial energetic changes induced by the new cardiotonic agent, AR-L 115, in patients with coronary artery disease.
    Thormann J; Kramer W; Schlepper M
    Am Heart J; 1982 Dec; 104(6):1294-302. PubMed ID: 7148647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemodynamics and metabolic-energetic expenses of the influence of AR-L115 in patients with coronary artery disease (author's transl)].
    Thormann J; Kramer W; Schlepper M
    Z Kardiol; 1981 May; 70(5):385-93. PubMed ID: 7269726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism and effects of the cardiotonic AR-L 115 BS in coronary heart disease: improved ventricular function and regional wall motility without angina pectoris].
    Thormann J; Schlepper M; Kramer W; Gottwik M
    Z Kardiol; 1982 Nov; 71(11):736-46. PubMed ID: 7157928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
    Benotti JR; Grossman W; Braunwald E; Carabello BA
    Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of AR-L 115 BS (Sulmazol), a new cardiotonic agent, in coronary artery disease: improved ventricular wall motion, increased pump function and abolition of pacing-induced ischemia.
    Thormann J; Schlepper M; Kramer W; Gottwik M; Kindler M
    J Am Coll Cardiol; 1983 Aug; 2(2):332-7. PubMed ID: 6863766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AR-L 115 in coronary artery disease: positive inotropic effects and increase of left-ventricular pump function without inducing angina.
    Thormann J; Schlepper M; Kramer W
    Clin Exp Pharmacol Physiol; 1982; 9(3):235-43. PubMed ID: 7140005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and myocardial energetic effects of CK-3197, a selective positive inotropic agent.
    Greenberg S; Touhey B
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):145-53. PubMed ID: 1708048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dobutamine on left ventricular performance and myocardial metabolic demands in patients with ischemic heart disease.
    Côté P; Bourassa MG; Tubau JF; Enjalbert M; Vandormael M
    Clin Cardiol; 1984 Jan; 7(1):14-22. PubMed ID: 6705283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
    Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
    Cannon RO; Rosing DR; Maron BJ; Leon MB; Bonow RO; Watson RM; Epstein SE
    Circulation; 1985 Feb; 71(2):234-43. PubMed ID: 4038383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in coronary haemodynamics and myocardial metabolism at rest and during exercise after a cardiotonic drug (prenalterol) in patients with coronary artery disease.
    Westheim A; Bae E; Christensen CC; Fønstelien E; Grendahl H; Muller O
    Clin Physiol; 1988 Oct; 8(5):463-74. PubMed ID: 3191661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
    Heiss HW; Hasenfuss G; Holubarsch C; Meinertz T; Just H
    Am J Cardiol; 1987 Aug; 60(5):53C-56C. PubMed ID: 2956869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic and antiischemic effects of intravenous amiodarone.
    Remme WJ; Van Hoogenhuyze DC; Krauss XH; Hofman A; Kruyssen DA; Storm CJ
    Am J Cardiol; 1985 Mar; 55(6):639-44. PubMed ID: 3976504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamic effects of beta-adrenoceptor blocking agents in coronary artery disease.
    Yabe Y; Morishita T
    Jpn Heart J; 1987 Sep; 28(5):675-86. PubMed ID: 3430729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial metabolism and ventricular function following cold potassium cardioplegia.
    Fremes SE; Weisel RD; Mickle DA; Ivanov J; Madonik MM; Seawright SJ; Houle S; McLaughlin PR; Baird RJ
    J Thorac Cardiovasc Surg; 1985 Apr; 89(4):531-46. PubMed ID: 3872382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic and myocardial metabolic effects of the beta-agonist prenalterol in ischemic left ventricular dysfunction.
    Kirlin PC; Walton JA; Brymer JF; Beauman G; Pitt B
    J Cardiovasc Pharmacol; 1984; 6(5):852-8. PubMed ID: 6209491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
    Amin DK; Shah PK; Hulse S; Shellock FG; Swan HJ
    Am Heart J; 1984 Nov; 108(5):1285-92. PubMed ID: 6238513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.